Operator: Good day, and thank you for standing by. Welcome to the Moderna Fourth Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode.
Year in Review: A look back at some of the top stories in 2023 mihomepaper.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mihomepaper.com Daily Mail and Mail on Sunday newspapers.
First clinical trial reporting results of an mRNA therapeutic for intracellular protein replacementTo date, mRNA-3927 has been generally well-tolerated at the doses administered, with encouraging early